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ABSTRACT 
Antibacterial resistance has become a serious crisis for world health over the last few decades, so 
that new therapeutic approaches are strongly needed to face the threat of resistant infections. 
Transcription factor decoys (TFD) are a promising new class of antimicrobial oligonucleotides 
with proven in vivo activity when combined with a bolaamphiphilic cationic molecule, 12-bis-
THA. These two molecular species form stable nanoplexes which, however, present very scarce 
colloidal stability in physiological media, which poses the challenge of drug formulation and 
delivery. In this work, we reformulated the 12-bis-THA/TFD nanoplexes in a liposomal carrier, 
which retains the ability to protect the oligonucleotide therapeutic from degradation and deliver it 
across the bacterial cell wall. We performed a physical-chemical study to investigate how the 
incorporation of 12-bis-THA and TFD affects the structure of POPC- and POPC/DOPE liposomes. 
Analysis was performed using dynamic light scattering (DLS), ζ-potential measurements, small-
angle x-ray scattering (SAXS), and steady-state fluorescence spectroscopy to better understand the 
structure of the liposomal formulations containing the 12-bis-THA/TFD complexes. 
Oligonucleotide delivery to model Escherichia coli bacteria was assessed by means of confocal 
scanning laser microscopy (CLSM), evidencing the requirement of a fusogenic helper lipid for 
transfection. Preliminary biological assessments suggested the necessity of further development 
by modulation of 12-bis-THA concentration in order to optimize its therapeutic index, i.e. the ratio 
of antibacterial activity to the observed cytotoxicity. In summary, POPC/DOPE/12-bis-THA 
liposomes appear as promising formulations for TFD delivery. 
 
KEYWORDS 
Antimicrobial resistance; Cationic liposomes; Oligonucleotide therapeutics; Transfection; Small-
angle x-ray scattering  
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1. Introduction 
 
The emergence of drug-resistant microbial strains is a natural phenomenon that occurs when 
bacteria evolve and adapt to face the threats posed by antimicrobial agents [1]. However, this 
process has been greatly accelerated by the excessive and incorrect use of antibacterial drugs. This 
has resulted in the lack of available treatments for once curable infectious diseases [2,3], 
determining a world-wide health crisis as reported by the World Health Organization [4]. In this 
context, renewed interest by public and private initiatives has focused on innovative approaches 
[5]. Among several alternative approaches proposed [6–11], transcription factor decoys (TFD) 
have shown the potential to defeat resistant infections, such as those caused by Clostridium difficile 
in animal models [12], when combined with a bolaamphiphilic cationic delivery molecule (12-bis-
THA) to form nanosized association complexes, termed nanoplexes. 
TFDs are short oligonucleotides consisting of base sequences that mimic the binding site to 
transcription factors, and they can block essential genetic pathways in bacteria, thereby preventing 
their survival response against antimicrobial attack [13]. The cationic surfactant 12-bis-THA is a 
bolaamphiphile with a molecular structure reminiscent of dequalinium, which is prescribed as a 
topical treatment for various bacterial infections. Besides its intrinsic antibacterial activity, owing 
to the positive electrostatic charge, dequalinium has been studied as a scaffold for gene delivery 
systems [14]. Similarly, 12-bis-THA plays a fundamental role in forming nanoplexes with 
oligonucleotides, which are condensed into a psi-form [15]: this structural rearrangement affords 
both resistance to DNA degradation [16] and DNA delivery into live cells [17]. The condensation 
process is reversible, as the fully renatured oligonucleotide can be released from the complex with 
12-bis-THA by displacing it with a competing anionic molecule [15]. 
12-bis-THA/TFD nanoplexes have been shown to be active in animal studies [17], but it is 
known that their colloidal stability needs to be improved prior to preclinical development, as they 
have the tendency to form insoluble precipitates in conditions of physiological ionic strength. The 
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optimized delivery system would also have controllable physical-chemical properties, as these 
affect the biodistribution of the nanoplexes and thus which infections can be treated. All of these 
requirements can be met by liposomes (or small unilamellar vesicles, SUV):  these can be 
formulated from biocompatible lipids, and they have been successfully used as drug carriers [18] 
and transfection vectors [19]. In particular, several antibiotics already commercially distributed 
are formulated on a liposomal scaffold [20], and liposomes have been proposed as antisense DNA 
vectors to bacteria [21]. 
In the present work, we redesigned the 12-bis-THA/TFD antimicrobial complex in a stable 
liposomal formulation that can retain delivery to the bacterial cytoplasm. Given the amphiphilic 
nature of 12-bis-THA, the encapsulation of nanoplexes in liposomes poses some challenges. A 
physical-chemical study was therefore necessary to assess the possible influence of the payload on 
liposomal stability and bilayer integrity [22,23]. Therefore, we first investigated the effect of 12-
bis-THA on the structure of liposomes based on classic lipids, i.e. neat POPC or a POPC/DOPE 
mixture; next, the formulations were investigated in depth to elucidate the nanoscale features of 
the bilayer, focusing in particular on the POPC/DOPE scaffolds. A preliminary biological 
evaluation was carried out to assess the transfection ability to model bacteria, the antibacterial 
activity and the cytotoxicity of these promising formulations. 
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2. Materials and methods 
 
Materials 
POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and DOPE (1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine) were purchased from Avanti PolarLipids (Alabaster, AL). 
12-bis-THA (1,1'-(dodecane-1,12-diyl)-bis-(9-amino-1,2,3,4-tetrahydroacridinium) (chloride 
or iodide) was synthesized by Shanghai Chempartners & co. LTD. 
Ultrapure water was obtained by means of a Millipore Elix® 3 water purification system. 
 
Oligonucleotide synthesis 
The oligonucleotide TFDs used in this work were manufactured and purified through HPLC at 
AxoLabs (Kulmbach, Germany). The TFD used for structural studies has been described 
elsewhere [15]; it consists of 77 base pairs containing the binding site for the sigma factors of RNA 
polymerase SigH. The fluorescently labeled Alexa488-Fur TFD was used in imaging and 
biological assays and contained the binding site for E. coli Fur transcription factor. Its sequence 
was: 5’-Alexa488-TEG-CGA TAG AAG TGG ATT TTT CCA CTT CTA* T*C*G-3’, where 
TEG is a tetraethyl glycol linker and the last nucleotides followed by an asterisk contain a 
phosphorothioate backbone. 
 
Stability of 12-bis-THA/TFD nanoplexes 
To prepare 12-bis-THA/TFD nanoplexes in water, 500 µL of a water stock solution of 12-bis-
THA at a concentration of 0.23 mg/mL were mixed with 490 µL H2O and vortexed for 30 s. Then, 
10 µl of TFD aqueous solution (1 mg/mL) were added, and vortexed for 30 s more. The nanoplexes 
thereby obtained were characterized by a positive-to-negative charge ratio Z+/- = 11. 
To prepare particles in saline solutions, 500 µL of a water stock solution of 12-bis-THA at a 
concentration of 0.23 mg/mL were mixed with 390 µL H2O and vortexed for 30 s. Then, 10 µl of 
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TFD aqueous solution (1 mg/mL) were added, and vortexed for 30 s more. Finally, 100 µL of 1.5 
mol/L solutions of sodium chloride (NaCl) and sodium citrate (Na3Cit) were added to the particle 
solution. 
 
Preparation of multilamellar vesicles and liposomes 
The lipids POPC and DOPE were weighed in order to obtain a POPC:DOPE = 7:3 weight ratio, 
in such a way as to obtain a final total concentration of 5 mg/mL lipids in the liposomal 
suspensions. The lipids were firstly dissolved and thoroughly mixed in chloroform or 
chloroform/methanol. The solvent was evaporated using a gentle N2 flow, and the lipid films were 
further dried by vacuum pumping for at least 8 hours. The films were hydrated with water or with 
a TFD solution, depending on the particular protocol, and the mixture was vortexed to obtain a 
suspension of multilamellar vesicles. In a typical sample, the lipids-to-12-bis-THA mole ratio 
would be 20:1, while the mole ratio between the bolaamphiphile and the oligonucleotide would be 
860:1 (which affords Z+/- = 11), unless specified differently. 
In order to obtain liposomes, the mixture underwent ten freeze-and-thaw cycles (from liquid 
nitrogen to a 50 °C water bath), unless the oligonucleotide was already present. Eventually, the 
suspension was extruded ten times through a polycarbonate filter (pore size = 100 nm).  If 12-bis-
THA was not in the initial dry film, it would be incorporated in the liposomes by a surface 
decoration method as follows: the bolaamphiphile was dissolved in methanol, then a dry film was 
obtained by evaporating the solvent under N2, and the appropriate amount of liposomal dispersion 
was poured on top of the dry film. The sample was vortexed and then kept in orbital stirring for 
approximately 10 hours. 
 
12-bis-THA quantification in liposomes 
The concentration of 12-bis-THA in the liposomes was ascertained by HPLC analysis, using a 
Zorbax Eclipse XDB-C18 column (150 ´ 4.6 mm, 5 µm). The chromatography was carried out at 
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a flow rate 1 mL/min in isocratic conditions, where the mobile phase was KH2PO4 (20 
mM)/acetonitrile/triethylamine (60:40:0.5 v/v/v) at pH = 3.8. UV-detection of 12-bis-THA was 
performed at λ = 254 nm. 
 
TFD quantification in liposomes 
The TFD concentration in liposomes was assessed using the Quant-iT™ OliGreen® fluorescent 
DNA staining dye (Life Technologies). A fluorescence intensity vs. TFD concentration standard 
curve was realized by recording the emission spectra of OliGreen® on a LS50B spectrofluorimeter 
(Perkin-Elmer, Italy); the spectra were acquired in the corrected mode, with an excitation 
wavelength of 480 nm and 10 nm slits, and the intensity at the emission maximum (520 nm) was 
plotted against [TFD]. Liposomal samples were diluted appropriately to fit in the linear range. The 
amount of TFD encapsulated in the liposomes was estimated by measuring the fluorescence of the 
OliGreen dye before and after the disruption of liposomes with 1 wt% Triton X-100. For each 
sample, 3 acquisitions were collected at 25 °C and averaged. 
 
Differential scanning calorimetry (DSC) 
DSC analysis was performed with a Q2000 DSC, TA Instruments (New Castle, USA). Roughly 
30 mg of each sample were placed in aluminum hermetic pans and analyzed scanning the 
temperature between 0 °C and 50 °C at 5 ºC/min. 
 
Dynamic light scattering (DLS) 
DLS analysis was used to infer the size and polydispersity of 12-bis-THA/TFD nanoplexes and 
of liposomes. For the nanoplexes, a Malvern ZetaSizer ZS was used, having a red laser (λ = 630 
nm) and the detector placed at 173°. For the liposomes, the instrument used was a Brookhaven 
BI9000-AT digital autocorrelator, equipped with a green laser (λ = 532 nm; Torus, mpc3000, 
LaserQuantum, UK) and an APD detector placed at 90°. In both cases, the hydrodynamic 
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diameters were calculated by cumulant analysis of the autocorrelation functions to extract the 
diffusion coefficients of the dispersed particles, which were then converted into sizes by assuming 
a spherical shape via the Stokes-Einstein equation. 
 
Zeta-potential measurements 
ζ-potentials were obtained from phase analysis light scattering (PALS) analysis, performed on 
a Brookhaven ZetaPALS instrument, equipped with a laser operating at 659 nm. The scattered 
intensity was collected at 15° to determine the electrophoretic mobility; the ζ-potentials were then 
calculated through the Helmholtz–Smoluchowski equation. 
 
Small angle x-ray scattering (SAXS) 
SAXS analysis of multilamellar vesicles was carried out with a Kratky camera system 
(HECUS). The incident beam was a CuKα radiation (λ = 1.542 Å) produced by a sealed-tube 
generator (Seifert ID-303) operating at 1.5 kW; the CuKβ radiation was removed thanks to a 10 
µm thick Ni filter. The detector (OED 50 M) contained 1024 channels of width 54 µm, and the 
sample-to-detector distance was 274 mm. The available Q-range was 0.01-0.55 Å. All 
measurements were performed at 25 °C (temperature controlled by a Peltier element, accuracy 
±0.1 °C); the samples were inserted in either a quartz Mark capillary (1.5 mm diameter) or a paste 
sample holder, depending on their viscosity, and the cells were kept under vacuum during the 
experiment. 
SAXS analysis of liposomes was conducted at the Austrian SAXS beamline (Elettra 
Synchrotron, Trieste, Italy). The samples were placed in quartz Mark capillaries of 1 mm 
thickness, enclosed in a steel cell; the same capillary was used for the blank to subtract to each 
sample. Scattering patterns were recorded at room temperature, on a Mar300-image-plate detector 
(MarResearch, Norderstedt, Germany), by irradiating the samples with an x-ray beam at an 8 keV 
energy. Irradiation times were in the order of 30 seconds, and for each sample 3 spectra were 
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acquired and averaged. The sample-to-detector distance of 1308 mm allowed to access a 0.0067-
0.46 Å-1 Q-range. 
Data reduction and background subtraction were performed with the software IGOR Pro 
(Wavemetrics, Inc.) [24]. Curves obtained with the Kratky camera were iteratively desmeared 
using the procedure reported by Lake [25]. Data modelling was carried out with the software GAP, 
provided by Prof. Georg Pabst (Graz University, Austria) [26]. 
 
Confocal laser scanning microscopy (CLSM) 
E. coli strain DH5α was grown to mid-log growth (Optical Density 0.2 - 0.3 at 630 nm) in LB 
broth. Fresh culture was mixed with an equal volume of liposomes loaded with an Alexa-Fluor488-
labelled TFD (λ ex488/em519) and incubated at room temperature for a total of 1.5 hours, under 
constant agitation in the dark. For the last 30 minutes, the bacterial membrane was labelled with 
the fluorescent membrane dye WGA-TMR (λ ex555/em580 nm, Life Technologies, UK) at a final 
concentration of 10 µg/ml. The samples were smeared onto poly-L-lysine coated slides (Sigma-
Aldrich, UK) and incubated for a further 1 hour in the dark at room temperature. Slides were then 
gently washed with filtered-sterilized PBS and dried in the air. Microscopy slides were kept in the 
dark at 4 °C prior to analysis by confocal microscopy using either a Leica TCS SP5 confocal 
microscope or a Leica TCS SP2, using a 63´ oil immersion objective or a 63´ water immersion 
objective, respectively. In both cases, the images were acquired with 488 nm Argon laser excitation 
(λ em498/ex530 nm) for Alexa488-labeled TFD and with DPSS 561 nm laser excitation (λ 
em571/ex620 nm) for WGA-TMR dye labeling the bacterial membrane. 
 
Biological assays 
Brief experimental methods for three biological assays are included below. Further details can 
be found in the Supplementary Methods section. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
10 
 
-Antibacterial activity (MIC test). The antibacterial activity of 12-bis-THA−containing 
formulations was tested against Escherichia coli DH5α using standard procedures, where changes 
in the optical density (630 nm) after overnight growth is interpreted as bacterial growth inhibition. 
Bacteria were incubated with liposomes in a concentration range between 5.3´10-4 and 5.3 ´10-7 
mol/L for the lipids (corresponding to 18 - 0.018 μmol/L for 12-bis-THA and 1 - 0.001 µg/mL for 
TFDs).  
-In vitro cytotoxicity studies (MTT assay). Caco-2 cells were grown to 70-80% confluency in 96 
well plates, then exposed to liposomes in a concentration range of lipids between 2.65´10-3 and 1 
´10-5 mol/L (corresponding to 90 µmol/L and 0.34 µmol /L of 12-bis-THA and 5 to 0.02 µg/mL of 
TFDs) in serum-free culture medium. After 24 h the formulation was removed and the cell viability 
examined by measuring the mitochondrial reduction of MTT using A570nm.  
-Xenopus laevis toxicity assay. All experiments were performed in compliance with the relevant 
laws and institutional guidelines at the University of East Anglia. The research has been approved 
by the local ethical review committee according to UK Home Office regulations. Xenopus laevis 
embryos were obtained as previously described [27]. X. laevis embryos at stage 38 were exposed 
to liposomes ± 12-bis-THA and TFD at concentrations ranging from 2.65´10-3 to 4 ´10-5 mol/L 
of lipids, corresponding to 90 µmol/L and 1.36 µmol /L of 12-bis-THA and 5 to 0.08 µg/mL of 
TFDs. Embryos were incubated at 18 °C until they reached stage 45.  
 
 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
11 
 
3. Results and Discussion 
 
We recently showed, using a range of complementary physical techniques, that 12-bis-THA 
(Scheme 1) complexes TFDs into a highly compacted, nuclease-resistant “psi” form in aqueous 
solution [15]. 
 
 
Scheme 1. Molecular structure of 12-bis-THA. 
 
Here we studied the kinetics of nanoplex stability by dynamic light scattering (DLS), 
monitoring the variation of hydrodynamic diameter (DH) and average scattered intensity (Iav) in 
water and in saline media at physiological ionic strength. As illustrated in Figure 1A, nanoplexes 
in H2O stored at 4 °C were stable for at least 72 h in terms of size. The stability of particles in 
water at RT (Figure 1B) was limited to 24 h, when they were observed to become slightly larger; 
in seven days, the size had increased by almost 100% while the scattering intensity was reduced 
by 7.5 times (data not shown). Indeed, since the light scattered by colloidal objects in solution is 
proportional to their concentration, such a dramatic decline of Iav clearly indicates the steep 
decrease of the number of suspended particles in solution as they progressively precipitate. The 
few particles remaining in suspension became larger over time due to coalescence and would most 
likely precipitate in time. Near instantaneous aggregation was observed after incubating the 
nanoplexes in saline solutions with physiological ionic strength (sodium citrate or sodium chloride, 
150 mM). This phenomenon is expected, due to the electrostatic origin of colloidal stability in 
water. The screening of the electrostatic charge of ionic colloids in the presence of dissolved salts, 
according to the DLVO theory of colloidal stability, triggers aggregation and eventually 
precipitation [28]. At the same time, this denotes the marked instability of the 12-bis-THA/TFD 
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antibacterial complex in saline media. In light of these results, we resorted to the reformulation of 
the 12-bis-THA/TFD nanoplexes in a lipid-based scaffold. 
 
 
 
Figure 1. Colloidal stability of 12-bis-THA/TFD polyplexes in different media: (A) water, 4 °C; (B) 
water, RT; (C) NaCl 150 mM, RT; (D) sodium citrate 150 mM, RT. Samples were analysed by light 
scattering analysis. DH (nm) = hydrodynamic diameter; Iav (kcps) = average scattering intensity. Lines are 
not data fits but a guide for the eye. Data shown are mean ± standard deviation. 
 
 
 
 
Reformulation of nanoplexes into POPC- and POPC/DOPE liposomes 
Liposomes for drug delivery are typically obtained with biocompatible lipids. We report here 
on the incorporation of 12-bis-THA and the loading of a model TFD in two lipid systems: one 
based on pure POPC and another based on the mixture of POPC and DOPE (1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine) in a 7:3 weight ratio. DOPE has been used for a long time as a 
helper lipid to promote fusion of liposomes with biological membranes, with proven ability to 
boost DNA transfection [29] and antibiotic efficacy [30]. 
The symmetric bolaamphiphile 12-bis-THA is poorly soluble in water and does not behave like 
a typical surfactant, as it has no clear-cut critical micellar concentration [15]. However, the 
presence of two cationic headgroups along with a 12-C aliphatic chain spacer suggests the 
possibility of amphiphilic behaviour. In order to assess the effect of the bolaamphiphile on the 
integrity of lipid bilayers, we firstly incorporated 12-bis-THA into liposomes following two 
different paths. In the “co-extrusion method”, 12-bis-THA (0.2 mM) was mixed with other lipids 
(5 mg/mL) in the initial dry film before hydration and membrane extrusion. In the “surface 
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decoration method”, pre-extruded liposomes were added to a dry film of 12-bis-THA to allow the 
uptake of the bolaamphiphile into the bilayers. The two protocols are represented in Scheme 2. 
 
 
 
Scheme 2. Pictorial representation of the two protocols employed for liposome preparation. 
a) “Co-extrusion” method: lipids and 12-bis-THA are both present in the initial dry film; 
b) “Surface decoration” method: only lipids are present in the initial dry film; 12-bis-THA 
is added to liposomes after extrusion. 
 
Composition DH (nm) PDI ζ-Pot (mV) 
POPC 109 ± 1 0.07 −23 ± 2 
POPC + 12-bis-THA 
(20:1 mole ratio) 
co-extruded 105 ± 2 0.09 +20 ± 3 
decoration 120 ± 2 0.10 +16 ± 1 
POPC/DOPE 111 ± 2 0.04 −16 ± 4 
(POPC/DOPE) + 12-bis-THA 
(20:1 mole ratio) 
co-extruded 115 ± 4 0.04 +20 ± 1 
decoration 124 ± 2 0.16 +28 ± 2 
Table 1. Physical-chemical characterization of liposomes (lipids: 5 mg/mL, with POPC:DOPE = 
70:30 %wt) without and with 12-bis-THA, incorporated via two different protocols. 
Hydrodynamic diameters (DH, nm) and size polydispersity (PDI) obtained by cumulant analysis 
of the DLS autocorrelation functions; ζ-potentials (ζ-Pot, mV) obtained by PALS analysis of the 
same samples. Data are mean ± standard deviation. 
 
The physical-chemical characterization of such liposomes is given in Table 1. For both POPC- 
and POPC/DOPE systems, the initial negative ζ-potentials of pure liposomes reversed upon 
introduction of 12-bis-THA, confirming the binding of the bolaamphiphile to liposomes with both 
methods. The co-extrusion protocol originated smaller POPC- and POPC/DOPE liposomes than 
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the decoration method, suggesting that in the former 12-bis-THA partitions between the inner and 
outer leaflet of the bilayer, while in the latter the bolaamphiphile accumulates at the liposomal 
surface. Importantly, the ζ-potentials of the vesicles decorated with 12-bis-THA remained constant 
around the value +25 mV (within the error bar; data not shown) even after an 80-fold dilution, 
demonstrating that the bolamphiphile is strongly associated with the bilayer and does not desorb 
upon dilution. 
Although the hydrodynamic size increased, 12-bis-THA did not change the morphology of 
liposomes, as demonstrated in a cryo-TEM image (Figure S1, Supporting Information) showing 
spherical liposomes made of POPC and 12-bis-THA introduced by surface decoration. Most 
importantly, POPC- and POPC/DOPE liposomes containing 12-bis-THA did not show any 
precipitation or other signs of colloidal instability when diluted 1:10 and 1:20 with high ionic 
strength media such as LB broth NaCl 150 mM solution (data not shown), contrary to the neat 12-
bis-THA/TFD nanoplexes. 
However, HPLC analysis of the liposomal dispersions obtained by co-extrusion revealed that 
approximately 50% of the 12-bis-THA was incorporated into the final liposome suspension (data 
not shown). Similarly, we encountered a loss of oligonucleotide when loading a model TFD (12-
bis-THA/TFD charge ratio Z+/- = 22) into the liposomes using the co-extrusion protocol. Indeed, 
the extrusion process was extremely slow and difficult, suggesting rapid adsorption of material on 
the polycarbonate membrane. The TFD content in the extruded formulation was assessed by 
staining with the DNA-binding fluorescent probe OliGreen®, and compared to the TFD content of 
the dispersion of multilamellar vesicles (MLV) before extrusion (see Figure S2, Supporting 
Information). The assay yielded 84% (± 10%) of the theoretical TFD amount in the MLV 
dispersion after disruption of the membranes with Triton X-100, while in the extruded liposomes 
no DNA could be detected. This suggests that all the TFD was lost during the extrusion process. 
Several hypotheses can be formulated to possibly explain the loss of material described above. 
Firstly, DSC experiments ruled out the possible increase in the gel-to-fluid transition temperature, 
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Tm, for the lipid bilayers. Indeed, no transition peaks were observed in the 4 °C – 80 °C range (data 
not shown), which suggests that these lipid assemblies should be easily extruded at room 
temperature. In another possible scenario, the presence of both the TFD and 12-bis-THA in the 
initial lipid dry film may promote the formation of the strong complex between the two species 
directly in the hydrated bilayers, producing lipoplexes in a columnar phase, as observed in similar 
systems [31]. These species are often rigid and larger than 100 nm, with a greater propensity to 
obstruct the membrane pores, impeding the passage of the dispersion. In order to examine for such 
liquid-crystalline phases, we carried out a small-angle x-ray (SAXS) investigation of the 
POPC/DOPE MLV systems, without and with added bolaamphiphile or TFD, before extrusion. 
 
 
 
Figure 2. SAXS patterns of POPC/DOPE bilayers: (A) neat; (B) with TFD; (C) with 12-bis-THA (20:1 
mole ratio); (D) with 12-bis-THA and TFD (Z+/- = 22). 
 
 
As shown in Figure 2, MLVs of POPC/DOPE without and with TFD (Figure 2A,B) display the 
typical pattern of a lamellar phase with Bragg peaks, which occur at Q = 2π/d values due to the 
interaction between adjacent lipid bilayers. From the first Bragg reflection order, we obtained the 
lamellar repeat spacing d = 62.8 Å for both samples (without and with TFD), indicating that there 
is no effect of the TFD on the bilayer structure. Further data modelling was performed by treating 
the structure factor S(Q) according to the Modified Caillé Theory [32], while the total scattering 
intensity I(Q) was modeled according to Equation 1:  
 
() =  
 !"##$%(&)'(&)* !"##'(&)
&+
        Eq. 1 
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which is a linear combination of the contributions S(Q) and P(Q) (form factor) weighed on the 
fraction Ndiff of positionally uncorrelated bilayers (i.e., unilamellar vesicles). The electron density 
of the lipid bilayer was modeled using three-Gaussian profiles [33]: two Gaussians represent the 
headgroups, centered at zH, and one Gaussian is used to represent the terminal −CH3 group at the 
bilayer’s center. The procedure allowed us to determine the center zH and the width σH of the 
Gaussians representing the headgroups, and to calculate the bilayer thickness (i.e. the headgroup-
to-headgroup thickness of the lipid double-layer) as: 
 
 = 2( + 2)         Eq. 2 
 
The salient structural features of a model bilayer, along with a typical electron density profile 
(ρ(z) as a function of the distance z from the bilayer center) are represented in Scheme 3, while fit 
results for the patterns in Figure 2 are displayed in Table 2. 
 
 
 
Scheme 3. Pictorial representation of a model lipid bilayer and the corresponding electron 
density profile, where: d = lamellar spacing; dW (Å): thickness of water layer between 
headgroups (MLV only); dB (Å): bilayer thickness; dH (Å): headgroup thickness; dC (Å): half 
thickness of hydrophobic region; zH (Å) and σH (Å): center and width, respectively, of the 
Gaussians representing the headgroups. 
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Parameter a b c d 
d (Å) 
62.82 
(±0.01) 
62.75 
(±0.01) 
N/A N/A 
zH (Å) 
19.4 
(±0.2) 
20.0 
(±0.1) 
17.5 
(±0.1) 
17.6 
(±0.1) 
σH (Å) 3 * 3 * 3 * 3 * 
Ndiff 0 0 1 1 
N. of 
lamellae 
25 
(±1) 
26 
(±1) 
N/A N/A 
dB (Å) 
51 
(±1) 
52 
(±1) 
47 
(±1) 
47 
(±1) 
dW (Å) 
12 
(±1) 
11 
(±1) 
N/A N/A 
 
Table 2. Results of SAXS data modelling (Figure 2) and calculation of some structural properties. d 
(Å): lamellar spacing; zH (Å) and σH (Å): center and width, respectively, of the Gaussians representing 
the headgroups; Ndiff: ratio of non-interacting bilayers (i.e. ULVs); N. of lamellae: average number 
of interacting lamellae; dB (Å): bilayer thickness; dW (Å): thickness of inter-lamellar water space. N/A 
= not applicable; * = constrained parameter. 
 
For the POPC/DOPE system, we determined dB = 51 Å without TFD and dB = 52 Å with TFD. 
Assuming the average headgroup thickness to be the weighted average of the phosphatidylcholine 
and phosphatidylethanolamine headgroups [34], dH = 8.9 Å, through an elementary geometric 
deduction (Scheme 1) we obtain for half the hydrophobic region dC ≈ 16 Å. This value is 
comparable to what reported in the literature for POPC bilayers at 2 °C [35], nevertheless, our 
calculated dC pertains to samples at 25 °C and is likely due to presence of 30% DOPE in the bilayer. 
However, care must be taken when dealing with SAXS patterns where less than four Bragg peaks 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
18 
 
are present, as the resolution of the electron density profile is low [36] and it is not always possible 
to discern the exact threshold between headgroup and tail Gaussians. 
The spectra pertaining to the samples containing also 12-bis-THA, with and without TFD 
(Figure 2C,D), are both consistent with the pure form factor P(Q) of non-interacting lipid bilayers, 
i.e. only unilamellar vesicles are present. These form spontaneously upon incorporation of 12-bis-
THA in the bilayer due to the positive charges of the bolaamphiphile molecules [37], as the bilayer 
bends in order to minimize repulsion between neighbouring headgroups, and the formation of 
MLVs is hindered by strong electrostatic repulsion between neighbouring bilayers. Interestingly, 
there is no trace of liquid-crystalline phases in the POPC/DOPE/12-bis-THA/TFD system. 
Evidently, the 12-bis-THA/TFD charge ratio used in this instance is too high to induce the 
formation of lipoplexes in columnar liquid-crystalline phases. Therefore, we can hypothesize that 
the reason for the observed loss of material during MLV extrusion could be the affinity of the 12-
bis-THA/TFD complex for polycarbonate membranes. Indeed, in some experiments 12-bis-THA 
iodide (which is poorly water soluble; data not shown) has shown a marked tendency to adsorb on 
polycarbonate filters; the charge-neutralized complex with TFD might possess a similar affinity 
for the extrusion filters due to hydrophobic interactions. Another possible reason could be an 
increased permeability of the vesicles due to a detergency effect of 12-bis-THA, although 
preliminary studies involving the interaction of the bolaamphiphile with DPPC bilayers 
(unpublished) have shown that detergency should take place for higher 12-bis-THA concentrations 
than those used in the present work. 
Eventually, we tackled this issue by turning to the surface decoration method. POPC- and 
POPC/DOPE dry films were hydrated with a TFD solution to increase the chance of encapsulating 
part of the DNA in the liposomal cores. After extrusion, 12-bis-THA was taken up from a dry film 
onto the pre-formed liposomes. ζ-potential measurements were positive whenever 12-bis-THA 
was included, even in the presence of the TFD (positive-to-negative charge ratio Z+/- = 22), and 
repeated DLS analysis showed no variation in either size, polydispersity index, or scattering 
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intensity of POPC and POPC/DOPE liposomes over at least three months (data not shown), 
attesting the high colloidal stability of these systems. Dilution of the formulations in saline NaCl 
150 mM did not lead to turbidity or precipitation. Therefore, both types of liposomes appear 
compatible, for size and surface charge as well as for their stability in time, with the desired 
application as gene delivery vectors. 
At this point, since the bolaamphiphile is in large excess compared to the oligonucleotide, one 
could argue that the addition of 12-bis-THA to the preformed liposomes in a TFD solution might 
lead to the formation of free TFD/12-bis-THA nanoplexes in the bulk solvent (Scheme 4, scenario 
b). 
 
 
Scheme 4. Schematic illustration of possible scenarios unfolding upon addition 
of 12-bis-THA to POPC/DOPE liposomes in a TFD solution. (a) 12-bis-THA 
adsorbs onto the lipid bilayer and attracts the TFD by electrostatic interaction. (b) 
12-bis-THA preferentially forms isolated nanoplexes with the TFD in the bulk 
solution. 
 
In order to confirm the localization of the TFD at the positively charged liposomal surface 
(scenario a in Scheme 4), the nanoscale structure of POPC/DOPE/12-bis-THA liposomes 
containing growing amounts of TFD was investigated by means of synchrotron SAXS. The spectra 
recorded for the systems with 0, 10, and 20 µg/mL TFD are shown in Figure 3 along with the 
respective best model fits obtained with Equation 1. 
 
 
Figure 3. SAXS patterns obtained for POPC/DOPE/12-bis-THA liposomes containing 
growing concentrations of TFD. Experimental data are represented with markers, while 
model curves are represented by lines. 
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The spectra are all similar and they show both a structure factor and a form factor. This suggests 
the presence of residual oligolamellar vesicles (OLV), where the bilayers are in interaction with 
each other: OLV contribute greatly to the scattered radiation even when they are present in very 
small numbers. Only two Bragg reflections are observed, due to bilayer disorder originating from 
bending fluctuation in the fluid Lα phase (third kind- or Caillé disorder) [36]. For the liposomes 
with no TFD, the fit results presented in Table 3 indicate that the SAXS pattern is consistent with 
a maximum number of 2 interacting lamellae; such bi-lamellar vesicles are present in very low 
number, since the contribution of the diffuse scattering is Ndiff = 97% of the total I(Q). The bilayer 
thickness calculated with Equation 2 is dB = 48 Å, in agreement with previous results (Table 2). 
 
 
Parameter 
[TFD] 
0 µg/mL 
[TFD] 
10 µg/mL 
[TFD] 
20 µg/mL 
d (Å) 
64.9 
(±0.2) 
64.3 
(±0.1) 
62.0 
(±0.2) 
zH (Å) 
17.79 
(±0.06) 
18.4 
(±0.4) 
15.93 
(±0.07) 
σH (Å) 
2.996 
(±0.004) 
3.2 
(±0.4) 
3 
(±1) 
Ndiff 
0.972 
(±0.001) 
0.9638 
(±0.0008) 
0.969 
(±0.001) 
N. of 
lamellae 
2.000 
(±0.000) 
2 * 2 * 
dB (Å) 
48 
(±1) 
50 
(±1) 
N/A 
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Table 3. Results of SAXS data modelling of the samples of Figure 3 with GAP software and 
calculation of some structural properties. d (Å): lamellar spacing; zH (Å) and σH (Å): center and 
width, respectively, of the Gaussians representing the headgroups; Ndiff: ratio of uninteracting 
bilayers (i.e. ULVs); N. of lamellae: average number of interacting lamellae; dB (Å): bilayer 
thickness. * = constrained parameter. 
 
In liposomes with 10 µg/mL TFD, the quality of the fitting was slightly poorer than for the 
spectrum of neat POPC/DOPE/12-bis-THA liposomes. Here, the number of interacting lamellae 
was constrained to 2 during the fitting procedure. The bilayer thickness obtained from the electron 
density profiles was 50 Å, which is 2 Å larger than the value obtained for the sample without TFD. 
At [TFD] = 20 µg/mL, data modelling with Equation 1 fails, most probably due to this model being 
unable to account for bilayer asymmetry. Such asymmetry between outer and inner lipid leaflets 
is suggested by the non-zero second node in the experimental scattering pattern [38], and can be 
explained by considering that the TFD molecules can only interact by charge compensation with 
the 12-bis-THA adsorbed on the outer liposomal leaflet. With growing TFD concentration, this 
effect becomes more evident ad more oligonucleotide accumulates at the surface. For this reason 
the scattering curves for the samples with [TFD] = 0 and 10 µg/mL can still be fitted using the 
model of Equation 1, but not the one with [TFD] = 20 µg/mL. This result supports the scenario in 
which no 12-bis-THA/TFD nanoplexes are formed in the bulk solution. This hypothesis is further 
reinforced by the fact that, upon dilution of the formulations in saline media, no turbidity or 
precipitation occur (data not shown). Indeed, since the nanoplexes are unstable in such media, as 
shown in the first part of this work, the absence of precipitate can safely be taken as proof that no 
free nanoplexes are present in the bulk solution of the liposomal formulations. 
Liposomes decorated with 12-bis-THA were also loaded with a fluorescently (green) labelled 
TFD and challenged against a standard laboratory E. coli strain, where the bacterial membrane 
was labelled with a red fluorophore. The samples were imaged by means of confocal laser scanning 
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microscopy (CLSM); at least 10 different fields of view were evaluated, with a total number of 
analyzed bacteria cells of approximately 5000. The detection limits of our CLSM experiments 
demanded the incubation of bacterial cells with relatively high concentrations of liposome 
suspensions, in the order of 2.65 mmol/L total lipids, corresponding to 90 uM of 12-bis-THA.  
In the case of the POPC/12-bis-THA/TFD systems, images (Figure 4a,b) clearly show an 
interaction with the bacterial membranes, with evident accumulation of green fluorescent material 
at the poles and the septa of the bacteria. These are the areas of the E. coli membrane especially 
rich in cardiolipin [39], a doubly-anionic lipid that is also present at high concentrations in the 
mitochondrial membrane of eukaryotic cells [40]. This result is in agreement with research 
involving the interaction of 12-bis-THA with model membranes [17] and the use of dequalinium 
as an efficient targeting system for mitochondria [41]. Moreover, a recent paper has demonstrated 
the key role of cardiolipin in the binding of cationic antimicrobial peptides and the perturbation of 
model bacterial membranes [42], which strengthens even more the idea that the affinity of certain 
cationic antimicrobials for cardiolipin could be exploited as an active targeting mechanism. 
However, the TFD release and delivery efficiency to the E. coli cytoplasm was low for POPC/12-
bis-THA/TFD liposomes, with less than 2% of the visualized cells presenting a diffuse intracellular 
green signal compatible with intracellular TFD release. 
 
 
Figure 4. Confocal microscopy images of the interaction between liposomes loaded 
with a fluorescent TFD (green) and E. coli bacteria (red). Separate channels and 
combined channels displayed. (a) and (b) POPC/12-bis-THA/TFD liposomes; (c) and 
(d) POPC/DOPE/12-bis-THA/TFD liposomes. 
  
The situation is rather different for POPC/DOPE liposomes: Figure 4c,d clearly show a diffuse 
green fluorescence in the bacterial cytoplasm, confirming the effective delivery of the TFD across 
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the E. coli membrane. This hints at the fundamental role of DOPE in promoting the fusion of 
liposomal bilayers with bacterial membranes, leading to the release of the TFD in the cytoplasm. 
Therefore, the fusogenic DOPE lipid is a key component for maximized delivery of the TFD 
nanoplexes to the bacterial cell. A possible explanation may lie in the fact that the E. coli inner 
membrane is composed of > 80% phosphatidylethanolamine lipids [43,44]. 
 
Biological evaluation of liposomes 
Liposomes based on the POPC/DOPE mixture were tested for their biological properties of 
interest, namely antibacterial activity and toxicity, in vitro and in vivo. To determine the activity 
of liposomal formulations on bacterial membranes a standard bacterial growth assay was used 
against the model Escherichia coli. As reported in Table 4, both POPC/DOPE/12-bis-THA and 
POPC/DOPE/12-bis-THA/TFD liposomes showed similar antibacterial activity of 1.1 μmol/L 
(with reference to 12-bis-THA, see Figure S3 for corresponding growth curves), which compares 
with that of the bare nanoplex [17]. Hence, despite the differences seen in the CLSM results 
concerning the efficacy of delivery for the two formulations (Figure 4), the membrane activity of 
the formulations was correlated to the concentration of 12-bis-THA. 
The cytotoxicity of liposomal formulations was evaluated by measuring IC50 values with the 
MTT assay on Caco-2 intestinal epithelial cells (Table 4). Liposomes devoid of 12-bis-THA 
inflicted no measurable cytotoxicity up to a concentration of ~ 0.5 mM total lipids. For 
POPC/DOPE/12-bis-THA and POPC/DOPE/12-bis-THA/TFD liposomes the values of IC50 were 
34 μM and 32 μM, respectively. The concentration of total lipids at these IC50 concentrations 
would be consistent with the 20:1 ratio of lipid:12-bis-THA, i.e. 680 and 640 μM, respectively. 
IC50 values were comparable to the values gained for other transfection agents [45–47] and 
approximately two-fold lower than that recorded for TFD/12-bis-THA nanoplexes [17]. The 
combination of improved colloidal stability of 12-bis-THA liposome formulations (cf. nanoplexes) 
and the presence of fusogenic DOPE increases the association with Caco-2 cells, as indicated by 
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flow cytometry analysis (Figure S5) with the likely consequence of increased membrane binding 
and subsequent intracellular penetration. 
 
Samples  
12-bis-THA 
MIC (µmol/L) 
12-bis-THA 
IC50 (µmol/L) 
POPC/DOPE -- ND 
POPC/DOPE/TFD -- ND 
POPC/DOPE/12-bis-THA/TFD 1.1 33.9 (± 1.4) 
POPC/DOPE/12-bis-THA 1.1 31.8 (± 3.1) 
Table 4. Biological evaluation of liposomes in antibacterial activity (MIC) against E. coli and 
cytotoxicity (IC50) in Caco-2 cells after 24 h exposure. ND: no observable toxicity at 
concentrations tested. Data are mean ± standard deviations. 
 
In order to extend the toxicity profile of these formulations, the toxicity of the liposomal 
formulations was also assessed using the Xenopus laevis embryo model. This model can help to 
bridge the gap between traditional in vitro and preclinical mammalian assays in biomedical 
research and drug development. Animal models to be employed for organism-based chemical 
screens have to be small, low-cost and compatible with simple culture conditions to be suitable for 
high-throughput screening [27]. Xenopus meets these requirements as its fertilization and 
embryonic development is external and they produce a large number of transparent embryos that 
are small enough to be placed in 48- or 96-well plates.  
The cumulative survival of the embryos after 96 h exposure with the liposomes is summarized 
in Figure 5. Liposomes containing no 12-bis-THA did not cause any toxicity to the larvae even 
after incubation at the highest dose (2.65 mM lipids). As seen with the eukaryotic cell model, the 
addition of 12-bis-THA into the liposomes strongly increased the formulation toxicity but no 
differences were observed between the 12-bis-THA–loaded liposomes and the 12-bis-THA–
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loaded liposomes with TFDs. Both of these 12-bis-THA–loaded liposomes display toxic potential 
in this animal model at the specific incubation conditions used (stage 38 to 45) above 5.6 μM 12-
bis-THA (0.16 mM lipids), a value in the same range as the IC50 values obtained for Caco-2 cell 
line (Table 4) confirming a good correlation between the eukaryotic and the Xenopus laevis model. 
The dynamics of the different liposome toxicity and the morphology of the surviving embryos (at 
stage 45) are reported as Supporting Information (Figure S6). Representative images show that the 
surviving embryos had no pattern of malformation or any visible phenotype related to toxicity 
(oedema, lack of pigmentation, bent spine, etc.) [48]. In summary these biological data indicate 
that the liposomal formulations retain antimicrobial activity and maintain a favourable in vitro 
activity-to-toxicity ratio (therapeutic index) [49] whilst improving the pharmaceutical properties 
of the nanoplexes. 
 
 
Figure 5. Xenopus laevis nanotoxicity assay. Xenopus laevis larvae survival after exposure to 
different liposome formulations from stage 38 to stage 45 at 18 ºC. Histograms shown are of 30 
embryos at each concentration. Date are mean ± S.D.  
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4. Conclusions 
 
Innovative approaches are needed to curtail antimicrobial resistance. TFDs are being developed 
as oligonucleotide antimicrobials to combat antibiotic resistance and a nanostructured formulation 
with 12-bis-THA has been shown to be efficacious in several models. In order to improve their 
stability, we have created liposomal formulations by decorating the surface of POPC and 
POPC/DOPE liposomes with 12-bis-THA, and exploited its ability to complex oligonucleotides 
to load a model TFD onto the lipid scaffolds. Confocal microscopy imaging was used to assess the 
ability of liposomes containing fluorescently labelled TFDs to transfect E. coli cells. In the case of 
the POPC formulations, images evidenced an interaction of liposomes with the bacterial 
membrane areas richer in cardiolipin, reinforcing the role of this negative lipid in the targeting for 
12-bis-THA, like other cationic antimicrobials, towards bacteria. However only POPC/DOPE 
liposomes effectively delivered the TFD to the E. coli cytoplasm, evidencing the requirement of a 
fusogenic helper lipid to successfully cross the bacterial membrane and boost transfection. 
POPC/DOPE liposomes therefore appear extremely promising as vector for the delivery of this 
new generation of antibacterial drugs. Preliminary biological assays demonstrated a non-negligible 
cytotoxic effect of 12-bis-THA towards human Caco-2 cells: future work will focus on the 
reduction of cytotoxicity by modulating the concentration of 12-bis-THA through its partial 
replacement with more biocompatible cationic lipids. 
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Highlights 
• A liposomal formulation is developed for antibacterial complex 
• The physical-chemical features of the liposomes are investigated 
• The delivery of the antibacterial oligonucleotide is assessed in E. coli 
